1)Tachimori Y, Ozawa S, Numasaki H, et al:Comprehensive Registry of Esophageal Cancer in Japan, 2009. Esophagus 13:110-137, 2016
2)Akutsu Y, Matsubara H:Chemoradiotherapy and surgery for T4 esophageal cancer in Japan. Surg Today 45:1360-1365, 2015
3)Dewan A, Sharma SK, Dewan AK, et al:Impact on Radiological and Pathological Response with Neoadjuvant Chemoradiation and Its Effect on Survival in Squamous Cell Carcinoma of Thoracic Esophagus. J Gastrointest Cancer 48:42-49, 2017
4)Oki E, Morita M, Kakeji Y, et al:Salvage esophagectomy after definitive chemoradiotherapy for esophageal cancer. Dis Esophagus 20:301-304, 2007
5)Picus D, Balfe DM, Koehler RE, et al:Computed tomography in the staging of esophageal carcinoma. Radiology 146:433-438, 1983
6)Yamabe Y, Kuroki Y, Ishikawa T, et al:Tumor staging of advanced esophageal cancer:combination of double-contrast esophagography and contrast-enhanced CT. AJR Am J Roentgenol 191:753-757, 2008
7)Akutsu Y, Shuto K, Kono T, et al:The number of pathologic lymph nodes involved is still a significant prognostic factor even after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma. J Surg Oncol 105:756-760, 2012
8)Yokota T, Kato K, Hamamoto Y, et al:Phase Ⅱ study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer. Br J Cancer 115:1328-1334, 2016
9)Okazumi S, Ochiai T, Shimada H, et al:Development of less invasive surgical procedures for thoracic esophageal cancer. Dis Esophagus 17:159-163, 2004